S. Hescot

1.6k citations

48 papers · 604 indexed · h-index 15

Impact in

Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension
- Pituitary Gland Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 25
- Thyroid Cancer Diagnosis and Treatment 13
- Hormonal Regulation and Hypertension 7
- Pituitary Gland Disorders and Treatments 7
Cancer Research 14
- Cancer, Hypoxia, and Metabolism 11

Co-authors: Éric Baudin (17 shared papers)Sophie Leboulleux (17 shared papers)Marc Lombès (11 shared papers)Julien Hadoux (19 shared papers)Séverine Trabado (3 shared papers)Angélo Paci (6 shared papers)Jacques Young (3 shared papers)A. Berdelou (5 shared papers)
Journals: Annals of Oncology (3 papers)Hormones and Cancer (3 papers)JCO Precision Oncology (2 papers)Endocrine Related Cancer (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
Partner nations: France United States Italy

In The Last Decade

S. Hescot

43 papers receiving 599 citations

Peers

Countries citing papers authored by S. Hescot

Since Specialization

Citations

This map shows the geographic impact of S. Hescot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hescot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hescot more than expected).

Fields of papers citing papers by S. Hescot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hescot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hescot. The network helps show where S. Hescot may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Hescot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Hescot Line = papers co-authored together S. Hescot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells Endocrine Related Cancer ·S. Hescot, Abdelhamid Slama, Anne Lombès, Angélo Paci, Hervé Remy, Sophie Leboulleux, Rita Chadarévian, Séverine Trabado, Larbi Amazit, Jacques Young, Éric Baudin, Marc Lombès	2013	76
2	Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials JCO Precision Oncology ·Elvire Pons‐Tostivint, Aurélien Latouche, Pauline Vaflard, Francesco Ricci, Delphine Loirat, S. Hescot, Marie‐Paule Sablin, Roman Rouzier, Maud Kamal, Claire Morel, Charlotte Lecerf, Vincent Servois, Xavier Paolettí, Christophe Le Tourneau	2019	72
3	Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT European Journal of Nuclear Medicine and Molecular Imaging ·Séréna Grimaldi, Jacques Young, Peter Kamenický, Dana M. Hartl, M. Terroir, Sophie Leboulleux, A. Berdelou, Julien Hadoux, S. Hescot, Hervé Remy, Éric Baudin, Martin Schlumberger, Désirèe Deandreis	2018	62
4	Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology Neuroendocrinology ·Jérôme Cros, Nathalie Théou–Anton, V. Gounant, Rémy Nicolle, Cécile Réyès, Sarah Humez, S. Hescot, Vincent de Montpréville, Serge Guyétant, Jean‐Yves Scoazec, Alice Guyard, Louis de Mestier, Solenn Brosseau, Pierre Mordant, Yves Castier, David Gentien, Philippe Ruszniewski, Gérard Zalcman, Anne Couvelard, Aurélie Cazes	2020	32
5	Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches Oncotarget ·S. Hescot, Larbi Amazit, Marie Lhomme, Simon Travers, Anais DuBow, S. Battini, Geoffrey Boulate, Izzie Jacques Namer, Anne Lombès, Anatol Kontush, Alessio Impériale, Eric Baudin, Marc Lombès	2017	28
6	Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma The Journal of Clinical Endocrinology & Metabolism ·S. Hescot, Atmane Seck, Maryse Guérin, F Cockenpot, Thierry Huby, Sophie Broutin, Jacques Young, Angélo Paci, Eric Baudin, Marc Lombès	2015	27
7	Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma Endocrine ·Guillaume Gravel, Sophie Leboulleux, Lambros Tselikas, Flora Fassio, Mohamed Berraf, A. Berdelou, Bakar Ba, S. Hescot, Julien Hadoux, Martin Schlumberger, Abir Al Ghuzlan, F. Nguyen, M. Faron, Thierry de Baère, Éric Baudin, Frédèric Deschamps	2018	22
8	Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT) JCO Precision Oncology ·Grégoire Marret, Ivan Bièche, Célia Dupain, Édith Borcoman, Pauline du Rusquec, Francesco Ricci, S. Hescot, Marie‐Paule Sablin, Patricia Tresca, Diana Bello, Coraline Dubot, Delphine Loirat, Maxime Frélaut, Charlotte Lecerf, Christophe Le Tourneau, Maud Kamal	2021	22
9	The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment Hormones and Cancer ·S. Hescot, Angélo Paci, Atmane Seck, Abdelhamid Slama, Say Viengchareun, Séverine Trabado, Sylvie Brailly‐Tabard, Abir Al Ghuzlan, Jacques Young, Eric Baudin, Marc Lombès	2014	21
10	[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab European Journal of Nuclear Medicine and Molecular Imaging ·Romain‐David Seban, Emilie Arnaud, Delphine Loirat, Luc Cabel, Paul Cottu, Lounes Djerroudi, S. Hescot, Pierre Loap, Claire Bonneau, François‐Clément Bidard, Virginie Huchet, Nina Jehanno, Arnaud Berenbaum, Laurence Champion, Irène Buvat	2023	21
11	F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients Thyroid ·M. Terroir, Caroline Caramella, Isabelle Borget, Sophie Giraud, Clarisse Dromain, K. El Farsaoui, Désirèe Deandreis, Séréna Grimaldi, J. Lumbroso, A. Berdelou, Julien Hadoux, S. Hescot, Dana M. Hartl, Éric Baudin, Martin Schlumberger, Sophie Leboulleux	2019	19
12	Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors Hormones and Cancer ·(unknown), Delphine Vezzosi, Christine Do Cao, S. Hescot, Jérôme Bertherat, Magali Haissaguerre, Vanina Bongard, D. Drui, Christelle de la Fouchardière, F. Illouz, Françoise Borson‐Chazot, Bodale Djobo, A. Berdelou, Antoine Tabarin, Martin Schlumberger, Claire Briet, Philippe Caron, Sophie Leboulleux, Rossella Libé, Éric Baudin	2017	16
13	Autocrine positive regulatory feedback of glucocorticoid secretion: Glucocorticoid receptor directly impacts H295R human adrenocortical cell function Molecular and Cellular Endocrinology ·Laetitia Asser, S. Hescot, Say Viengchareun, Brigitte Delemer, Séverine Trabado, Marc Lombès	2014	16
14	Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy Drugs in R&D ·Pauline Vaflard, Xavier Paolettí, Vincent Servois, Patricia Tresca, Elvire Pons‐Tostivint, Marie-Paule Sablin, Francesco Ricci, Delphine Loirat, S. Hescot, Nouritza Torossian, Diana Bello Roufai, Maud Kamal, Édith Borcoman, Christophe Le Tourneau	2021	15
15	Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry Experimental and Clinical Endocrinology & Diabetes ·Matthias Kroiß, Timo Deutschbein, Wiebke Schlötelburg, Cristina L. Ronchi, S. Hescot, Daniela Körbl, Felix Megerle, Felix Beuschlein, Bruno Neu, Marcus Quinkler, Eric Baudin, Stefanie Hahner, Anke Heidemeier, Martin Faßnacht	2018	15
16	Prognostic of recurrence and survival in poorly differentiated thyroid cancer Endocrine Related Cancer ·S. Hescot, Abir Al Ghuzlan, Théophraste Henry, Hala Sheikh Alard, Livia Lamartina, Isabelle Borget, Julien Hadoux, Éric Baudin, Corinne Dupuy, Alyaksandr V. Nikitski, Yuri E. Nikiforov, Martin Schlumberger, Marina N. Nikiforova, Sophie Leboulleux	2022	14
17	Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients Hormones and Cancer ·Julien Hadoux, M. Terroir, Sophie Leboulleux, Frédèric Deschamps, Abir Al Ghuzlan, S. Hescot, Lambros Tselikas, Isabelle Borget, Caroline Caramella, Désirèe Deandreis, Diane Goèré, Thierry de Baère, Martin Schlumberger, Éric Baudin	2017	13
18	Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma The Journal of Clinical Endocrinology & Metabolism ·Alice Boilève, Elise Mathy, Charles Roux, Matthieu Faron, Julien Hadoux, Lambros Tselikas, Abir Al Ghuzlan, S. Hescot, Sophie Leboulleux, Thierry de Baère, Livia Lamartina, Frédèric Deschamps, Éric Baudin	2021	13
19	Locally unresectable differentiated thyroid cancer: outcomes and perspectives Endocrine ·(unknown), Livia Lamartina, Yann Godbert, Cássia Danielle Lonardoni do Nascimento, Christine Do Cao, S. Hescot, Isabelle Borget, Abir Al Ghuzlan, Dana M. Hartl, Julien Hadoux, Edwige Pottier, Marie Attard, A. Berdelou, M. Terroir, Éric Baudin, Martin Schlumberger, Sophie Leboulleux	2020	12
20	Expert opinions on adrenal complications in immunotherapy Annales d Endocrinologie ·Michel Haı̈ssaguerre, S. Hescot, Jérôme Bertherat, Olivier Chabre	2018	12

About S. Hescot

S. Hescot is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Genetics, Neurology and Oncology, having authored 48 papers that have together received 604 indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (15 papers), Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (11 papers), Neuroendocrine Tumor Research Advances (8 papers), Hormonal Regulation and Hypertension (7 papers), Lung Cancer Research Studies (7 papers), Pituitary Gland Disorders and Treatments (7 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (222 citations), Endocrinology, Diabetes and Metabolism (233 citations), Nephrology (58 citations), Oncology (191 citations) and Surgery (285 citations). S. Hescot has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Éric Baudin, Sophie Leboulleux, Marc Lombès, Julien Hadoux, Séverine Trabado, Angélo Paci, Jacques Young, A. Berdelou, Martin Schlumberger and Delphine Loirat. Their work appears in journals such as Annals of Oncology, Hormones and Cancer, JCO Precision Oncology, Endocrine Related Cancer and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact